Sanofi/GSK launch Phase III trial of COVID-19 vaccine, will test efficacy against variants

Published on
27/05/2021 – 8:50 GMT+2

Sanofi and GlaxoSmithKline (GSK) announced on Thursday that they are launching large-scale trials for their COVID-19 vaccine.